Terlipressin bolus induces systemic vasoconstriction in septic shock.
To report the use of a synthetic, long-acting, vasopressin analog, terlipressin, as an effective vasoconstrictor in septic shock. Case report. A 22-bed pediatric intensive care unit in a tertiary referral center. An 11-yr-old male with multiple-organism Gram-negative septic shock with high normal cardiac output as assessed by pulse contour analysis and low systemic vascular resistance despite norepinephrine infusion. Two peripherally administered doses of terlipressin (0.5 mg). Each dose of terlipressin was associated with a rapid increase in systemic vascular resistance, despite weaning and discontinuation of norepinephrine infusion from 0.15 microg.kg(-1).min(-1) lasting approximately 6 hrs. Terlipressin may be useful for sepsis-induced vasodilation.